A new study published in the Journal of Cancer Survivorship sheds light on the prevalence and motives driving cannabis utilization among individuals who have triumphed over cancer.
See Also: Research Shows Cannabis Treatment Improves Cognitive Function, Reduces Pain And Depression Among Advanced Cancer Patients
Insights From the Study
- Conducted at a comprehensive cancer center in Houston, Texas, the study engaged 1,886 participants from 41 U.S. states undergoing cancer treatment.
- Notably, the research found that 17.4% of respondents were current cannabis users, 30.5% were former users, and 52.2% had never used marijuana.
- Among the 510 participants who turned to cannabis after their cancer diagnosis, 60% cited managing sleep disturbances, 51% pain, 44% stress, 34% nausea, and 32% mood disorders or depression as reasons, as per Marijuana Moment.
See Also: Breakthrough: Ibogaine Therapy Shows Promising Outcomes For Veterans With Traumatic Brain Injury
Evaluating Cannabis as Symptomatic Relief
Encouragingly, a substantial proportion reported significant symptomatic improvement, with 47.7% finding marijuana effective for cancer itself to a great extent, and 74% of those using it for nausea and vomiting perceiving substantial benefits.
However, the study also unveiled a low awareness among participants of potential health risks associated with cannabis use during cancer treatment. Only 1 in 10 participants were aware of such risks, including suicidal thoughts (5%), intense nausea and vomiting (6%), depression (11%), anxiety (14%), breathing problems (31%), and drug interactions (35%).
Recommendations from the Authors: Policy And Education
Researchers from the University of Texas’s MD Anderson Cancer Center emphasized the immediate need for medical guidance on cannabis use within the broader context of cancer treatment.
Blue Bird Corporation, a renowned school bus manufacturer, has recently made a notable move, catching the eyes of market players. In a technical twist, the stock surged past its 50-day simple moving average (SMA) - a crucial juncture for traders, heralding a promising short-term uptick.
Key Signals from Historical MovementsIntriguingly, this isn't the first time Blue Bird has crossed above the 50-day SMA. Earlier in the year, it made a similar breakthrough on May 3, maintaining the position until July 1. Despite a brief dip below the SMA in July, the stock reclaimed its territory yesterday. This rebound marks a positive trajectory for the company.
The Fundamental Strengths of Blue BirdDelving into Blue Bird's fundamentals, there are six notable reasons to be bullish on the stock:
Massive Market Opportunity: With a rich legacy spanning a century in crafting school buses, Blue Bird is leaping into the future with innovative advancements in automotive technology. The company's stronghold in the market, especially in the electric school buses segment, promises lucrative gains. Propane Advantage: Blue Bird doesn't just stop at electric buses; it also capitalizes on propane and gasoline, leveraging a strategic partnership to maintain its dominance in the alternative fuels domain. Favorable Government and Regulatory Policies: Riding on government initiatives promoting electric buses, Blue Bird stands to benefit from supportive policies paving the way for growth. Turnaround Efforts Paying Off: A resilient turnaround strategy post-pandemic hurdles has bolstered Blue Bird's financial health, propelling it towards profitability and enhanced operational efficiency. Expansion & Safety Initiatives: With a vision to scale up production and bolster safety protocols, Blue Bird is gearing up for an expansion spree, aligning with the escalating demand. Raised FY24 Guidance: Noteworthy revenue projections and an optimistic outlook underscore Blue Bird's confidence in its future performance.A Glance at Stocks in PerformanceBlue Bird's stock has had an impressive run this year, showcasing a robust 94% surge year-to-date, significantly outshining industry counterparts and market benchmarks. The stock's ascent paints a promising picture amidst a competitive landscape.
Charting Growth Trajectories & Valuation MetricsPeering into growth estimates and valuation ratios, Blue Bird stands out with a compelling growth narrative, with earnings poised to soar. The stock's forward-looking sales multiple and Value Score hint at a prudent investment opportunity, perched at an intriguing juxtaposition within the industry.
Deciphering Investment MovesAs Blue Bird's transformation story unfolds into one of growth and promise, investors are poised at a juncture of opportunity. With a steadfast focus on industry trends and the company's strategic roadmap, the decision to jump aboard the Blue Bird bandwagon beckons investors to ponder judiciously.
Blue Bird Corporation Poised for Growth Amid Market Demand“With most survivors reporting benefits from cannabis use in cancer management, there is a need for more studies to strengthen current evidence on cannabis therapeutics,” they stressed, also calling for the development of policies, clear guidelines, and educational programs for healthcare providers and survivors regarding the use, benefits, and risks of cannabis in cancer management.
As the medical community grapples with these findings, noteworthy industry players, including Verano Holdings Corp. VRNOF and TILT Holdings Inc. TLLTF, along with its subsidiary Standard Farms, have recently contributed to breast cancer awareness initiatives.
Read Next: Gardening Giant Scotts Miracle-Gro Invests Thousands Of Dollars In Initiative To Safeguard Medicinal Marijuana Patients’ Rights
Image by El Planteo
